CIK 0001818331 · Large accelerated filer
GeneDx Holdings Corp.
Sign in to watch- Ticker
- WGS
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851966622
- Phone
- 888-729-1206
- Business address
- 333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, STAMFORD, CT, 06902
- Former names
- Sema4 Holdings Corp., CM Life Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,839,245
- in 5 filings
Net −$1,839,245. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-29 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −388 | $105.31 | $41K | 3,757 |
| 2025-07-29 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −753 | 2,261 | ||
| 2025-07-29 | Stueland Katherine Chief Executive Officer | Option exercise | +3,874 | 5,594 | ||
| 2025-07-29 | Stueland Katherine Chief Executive Officer | Sale | −2,154 | $105.31 | $227K | 3,440 |
| 2025-07-29 | Stueland Katherine Chief Executive Officer | Option exercise · Restricted Stock Unit | −3,874 | 11,622 | ||
| 2025-07-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +1,245 | $32.67 | $41K | 8,670 |
| 2025-07-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −5,278 | $93.00 | $491K | 3,392 |
| 2025-07-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −1,245 | 6,228 | ||
| 2025-07-09 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −3,220 | $93.00 | $299K | 1,720 |
| 2025-07-01 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −6,928 | $90.68 | $628K | 7,669 |
| 2025-07-01 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −2,594 | $91.55 | $237K | 5,075 |
| 2025-07-01 | Stueland Katherine Chief Executive Officer | Sale 10b5-1 | −135 | $92.46 | $12K | 4,940 |
| 2025-07-01 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −998 | $90.86 | $91K | 7,771 |
| 2025-07-01 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −346 | $91.88 | $32K | 7,425 |
| 2025-06-18 | Casdin Eli Director | Option exercise | +12,924 | 20,518 | ||
| 2025-06-18 | Casdin Eli Director | Grant or award · Restricted Stock Unit | +3,576 | 3,576 | ||
| 2025-06-18 | Casdin Eli Director | Option exercise · Restricted Stock Unit | −12,924 | 0 | ||
| 2025-06-18 | Casdin Eli Director | Option exercise | +12,924 | 20,518 | ||
| 2025-06-18 | Casdin Eli Director | Grant or award · Restricted Stock Unit | +3,576 | 3,576 | ||
| 2025-06-18 | Casdin Eli Director | Option exercise · Restricted Stock Unit | −12,924 | 0 |
Page 15 of 23 · 450 trades